BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30909685)

  • 1. Gleason Pattern 5 is a Possible Pathologic Predictor for Biochemical Recurrence after Laparoscopic Radical Prostatectomy.
    Ikeda M; Amano N; Sakata Y; Honda T; Tachibana T; Hirano S; Yamashita H; Ishii J; Irie A
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):783-788. PubMed ID: 30909685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
    Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
    BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for short-term biochemical recurrence-free survival after robot-assisted laparoscopic radical prostatectomy in high-risk prostate cancer patients.
    Kanehira M; Takata R; Ishii S; Ito A; Ikarashi D; Matsuura T; Kato Y; Obara W
    Int J Clin Oncol; 2019 Sep; 24(9):1099-1104. PubMed ID: 30972506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
    Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
    Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomy.
    Adam M; Hannah A; Budäus L; Steuber T; Salomon G; Michl U; Haese A; Fisch M; Wittmer C; Steurer S; Minner S; Heinzer H; Huland H; Graefen M; Sauter G; Schlomm T; Isbarn H
    J Urol; 2014 Jul; 192(1):97-101. PubMed ID: 24518778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    J Urol; 2017 Apr; 197(4):1060-1067. PubMed ID: 27847296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model.
    Taguchi S; Uemura Y; Fujimura T; Morikawa T; Naito A; Kawai T; Suzuki M; Kume H; Fukuhara H
    BMC Cancer; 2020 May; 20(1):371. PubMed ID: 32357849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Gleason Score 7 With Tertiary Pattern 5 at Radical Prostatectomy.
    Borhan W; Epstein JI
    Urology; 2017 Feb; 100():175-179. PubMed ID: 27810358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy.
    Miyake H; Muramaki M; Furukawa J; Tanaka H; Inoue TA; Fujisawa M
    Urol Oncol; 2013 Nov; 31(8):1511-6. PubMed ID: 22658882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy.
    Mao Y; Li K; Lu L; Si-Tu J; Lu M; Gao X
    Cancer Biomark; 2016; 16(3):351-8. PubMed ID: 26889981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors for Biochemical Recurrence More than 10 Years after Radical Prostatectomy.
    Liesenfeld L; Kron M; Gschwend JE; Herkommer K
    J Urol; 2017 Jan; 197(1):143-148. PubMed ID: 27418452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer.
    Servoll E; Saeter T; Vlatkovic L; Lund T; Nesland J; Waaler G; Axcrona K; Beisland HO
    BJU Int; 2012 May; 109(10):1489-94. PubMed ID: 21933333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.
    Salomon L; Anastasiadis AG; Johnson CW; McKiernan JM; Goluboff ET; Abbou CC; Olsson CA; Benson MC
    Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical recurrence-free conditional probability after radical prostatectomy: A dynamic prognosis.
    García-Barreras S; Sanchez-Salas R; Mejia-Monasterio C; Muttin F; Secin F; Dell'Oglio P; Nunes-Silva I; Srougi V; Barret E; Rozet F; Prapotnich D; Cathelineau X
    Int J Urol; 2019 Jul; 26(7):725-730. PubMed ID: 31001870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy.
    Hashimoto T; Nakashima J; Inoue R; Komori O; Yamaguchi Y; Kashima T; Satake N; Nakagami Y; Namiki K; Nagao T; Ohno Y
    Int J Clin Oncol; 2020 Feb; 25(2):377-383. PubMed ID: 31673831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of Reporting the Gleason Score at the Positive Surgical Margin Site: Analysis of 4,082 Consecutive Radical Prostatectomy Cases.
    Kates M; Sopko NA; Han M; Partin AW; Epstein JI
    J Urol; 2016 Feb; 195(2):337-42. PubMed ID: 26264998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.